Effects of Motivational Interviewing on Adherence to Treatment Regimens Among Patients With Type 1 Diabetes: A Systematic Review.
Journal
Diabetes spectrum : a publication of the American Diabetes Association
ISSN: 1040-9165
Titre abrégé: Diabetes Spectr
Pays: United States
ID NLM: 8913432
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
entrez:
7
6
2019
pubmed:
7
6
2019
medline:
7
6
2019
Statut:
ppublish
Résumé
Motivational interviewing (MI) is a strategy for promoting adherence to treatment regimens among patients with diabetes. However, limited evidence exists regarding its effectiveness in reducing A1C. To identify and synthesize evidence about the effectiveness of patient, provider, and health system interventions to improve diabetes care among patients with type 1 diabetes. This was a systematic review of randomized controlled trials. A search was conducted of the scientific databases MEDLINE, Elsevier, CINAHL, Google Scholar, ProQuest, Ovid, and PubMed without imposing any time limit. Only four documents met the inclusion criteria and were included in the final analysis. The methodological quality of these four articles was reviewed by three reviewers using the Jadad Scale. The main intervention and the primary outcome in this study were MI or motivational enhancement therapy and A1C, respectively. The retrieved studies reported that MI promotes self-monitoring of blood glucose and reduces A1C. MI is effective in enhancing patients' adherence to the treatment regimen and thereby decreasing A1C. Given the fact that the reviewed studies had not eliminated the effects of confounding factors, further studies are needed to assess the pure effects of MI on adherence to treatment regimens and A1C levels.
Sections du résumé
BACKGROUND
BACKGROUND
Motivational interviewing (MI) is a strategy for promoting adherence to treatment regimens among patients with diabetes. However, limited evidence exists regarding its effectiveness in reducing A1C.
OBJECTIVE
OBJECTIVE
To identify and synthesize evidence about the effectiveness of patient, provider, and health system interventions to improve diabetes care among patients with type 1 diabetes.
DESIGN
METHODS
This was a systematic review of randomized controlled trials.
METHODS
METHODS
A search was conducted of the scientific databases MEDLINE, Elsevier, CINAHL, Google Scholar, ProQuest, Ovid, and PubMed without imposing any time limit. Only four documents met the inclusion criteria and were included in the final analysis. The methodological quality of these four articles was reviewed by three reviewers using the Jadad Scale. The main intervention and the primary outcome in this study were MI or motivational enhancement therapy and A1C, respectively.
RESULTS
RESULTS
The retrieved studies reported that MI promotes self-monitoring of blood glucose and reduces A1C.
CONCLUSION
CONCLUSIONS
MI is effective in enhancing patients' adherence to the treatment regimen and thereby decreasing A1C. Given the fact that the reviewed studies had not eliminated the effects of confounding factors, further studies are needed to assess the pure effects of MI on adherence to treatment regimens and A1C levels.
Identifiants
pubmed: 31168281
doi: 10.2337/ds18-0038
pii: 112
pmc: PMC6528390
doi:
Types de publication
Journal Article
Langues
eng
Pagination
112-117Références
Arch Dis Child. 2003 Aug;88(8):680-3
pubmed: 12876161
J Clin Epidemiol. 2006 Dec;59(12):1249-56
pubmed: 17098567
Diabetes Care. 2007 Jun;30(6):1390-5
pubmed: 17351283
Ann Intern Med. 2008 Nov 18;149(10):708-19
pubmed: 19017589
Int J Clin Pract. 2010 Feb;64(3):305-15
pubmed: 20456170
Diabetes Care. 2010 Aug;33(8):1741-3
pubmed: 20484124
Curr Opin Pediatr. 2010 Aug;22(4):405-11
pubmed: 20489639
Diabetes Care. 2010 Jul;33(7):1658-64
pubmed: 20587726
Endocrinol Metab Clin North Am. 2010 Sep;39(3):481-97
pubmed: 20723815
Wien Med Wochenschr. 2010 Aug;160(15-16):414-8
pubmed: 20812053
Diabetes Technol Ther. 2012 Jul;14(7):630-4
pubmed: 22524548
J Pediatr Psychol. 2013 Jul;38(6):629-37
pubmed: 23699750
Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S95-9
pubmed: 24251231
Diabetes Res Clin Pract. 2014 Feb;103(2):161-75
pubmed: 24331235
Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
pubmed: 24357215
Cochrane Database Syst Rev. 2014 Nov 20;(11):CD000011
pubmed: 25412402
BMJ Open Diabetes Res Care. 2016 Jun 01;4(1):e000165
pubmed: 27284455